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Abstract The X-Stop interspinous distraction device has
shown to be an attractive alternative to conventional
surgical procedures in the treatment of symptomatic
degenerative lumbar spinal stenosis. However, the effec-
tiveness of the X-Stop in symptomatic degenerative lumbar
spinal stenosis caused by degenerative spondylolisthesis is
not known. A cohort of 12 consecutive patients with
symptomatic lumbar spinal stenosis caused by degenerative
spondylolisthesis were treated with the X-Stop interspinous
distraction device. All patients had low back pain, neuro-
genic claudication and radiculopathy. Pre-operative
radiographs revealed an average slip of 19.6%. MRI of the
lumbosacral spine showed a severe stenosis. In ten patients,
the X-Stop was placed at the L4–5 level, whereas two
patients were treated at both, L3–4 and L4–5 level. The
mean follow-up was 30.3 months. In eight patients a com-
plete relief of symptoms was observed post-operatively,
whereas the remaining 4 patients experienced no relief of
symptoms. Recurrence of pain, neurogenic claudication,
and worsening of neurological symptoms was observed in
three patients within 24 months. Post-operative radiographs
and MRI did not show any changes in the percentage of slip
or spinal dimensions. Finally, secondary surgical treatment
by decompression with posterolateral fusion was performed
in seven patients (58%) within 24 months. In conclusion,
the X-Stop interspinous distraction device showed an
extremely high failure rate, deﬁned as surgical re-
intervention, after short term follow-up in patients with
spinal stenosis caused by degenerative spondylolisthesis.
We do not recommend the X-Stop for the treatment of
spinalstenosiscomplicatingdegenerativespondylolisthesis.
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Introduction
Lumbar spinal stenosis complicating degenerative spond-
ylolisthesis is a common cause for low back pain,
neurogenic claudication, and radiculopathy in the elderly
population. The majority of the patients will respond well
to non-operative treatment modalities. However, in patients
that fail to respond to conservative treatment, surgical
decompression with or without a posterolateral fusion and
instrumentation, may be considered [3, 12]. Unfortunately,
these procedures have variable long-term outcomes and are
frequently followed by complications, especially in the
elderly patients with high co-morbility [2, 10]. Therefore,
alternative therapies are being developed, of which the
interspinous distraction device is rapidly gaining popularity
[4, 9]. Of such, the X-Stop (X-Stop, St. Francis Medical
Technologies, Inc
1, Alameda, CA) has been introduced as
a minimal invasive surgical procedure to treat symptomatic
degenerative lumbar spinal stenosis [4, 9]. Initial results of
the treatment of degenerative lumbar spinal stenosis with
the X-Stop are promising [8, 13, 14]. Recently, encourag-
ing results have been reported for the treatment of patients
with symptomatic lumbar spinal stenosis caused by
degenerative spondylolisthesis [1]. However, we observed
an alarmingly high failure rate, deﬁned as surgical
re-intervention, in a cohort of patients treated with the
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degenerative spondylolisthesis. This prompted us to per-
form a retrospective chart review, and analysis of the
radiographs.
Patients and methods
We retrospectively reviewed 12 consecutive patients with
symptomatic lumbar spinal stenosis caused by degenera-
tive spondylolisthesis treated with the X-Stop interspinous
distraction device. The patients were treated between Jan-
uary 2003 and May 2005. There were 9 female and 3 male
patients with a mean age at surgery of 67.5 years (50–83).
All patients complained of progressive low back pain
throughout the day with neurogenic claudication, radicul-
opathy and a diminished walking distance. In all patients,
neurological examination was judged normal or nonspe-
ciﬁc. Anteroposterior, lateral and ﬂexion/extension plain
radiographs, and magnetic resonance imaging (MRI) were
performed in all cases. The percentage of degenerative slip
was measured on the lateral radiograph and measured
according to the method described by Anderson et al. [1].
The anteroposterior dural sac diameter in the axial and
sagittal plane T2 sequence was measured on the MRI. A
standardized walking and cycling test [6] was performed at
the department of physical therapy. A limited walking
distance less than 1 km (0.62 miles) independent of the
time needed, was considered positive. After walking the
patient had to sit and the pre-walking pain must be reduced
in less than 5 min. Cycling should be unlimited without
complaints. Initial treatment consisted on patient educa-
tion, medications to control pain, and exercise and physical
treatments to regain or maintain activities of daily living.
Surgical treatment with the X-Stop was considered in
patients not improving with conservative care for more
than 6 months.
All operations were performed under general anesthesia.
The patients were placed in prone position on a Wilson
spinal surgery frame (Orthopaedic Systems, Inc., Union
City, CA) with the lumbar spine in maximum ﬂexion.
Prophylactic antibiotics, cefazolin (cefalosporin, Kefzol
1)
1,000 mg IV, were administered at the induction of anes-
thesia, and as a second and third dose 8 and 16 h post-
operatively, respectively. After radiographic identiﬁcation
of the surgical level, a mid-sagittal incision of approxi-
mately 4 cm is made over the spinous processes. The
musculature was elevated to the level of laminae and fac-
ets. The supraspinal ligament is kept intact. To pierce the
interspinous ligament, a curved dilator is inserted in the
anterior margin of the interspinous space. Subsequently, a
sizing distractor is inserted to determine the appropriate
implant size. The X-Stop is inserted into the interspinous
space as close to the posterior aspect of the lamina as
possible. An adjustable wing is attached to the implant and
secured along the midline. Patients were mobilized
immediately once they had recovered from the anesthetic
effects. They were discharged from hospital within 48 h.
Clinical follow-up took place at 6 and 12 weeks and at
12 and 24 months. All patients underwent a clinical and
radiographic examination of the lumbar spine in standing
position at each follow-up visit. The mean follow-up was
30.3 months (13–41). In patients with persistent or recur-
rence low back pain with neurogenic claudication and
radiculopathy, a second MRI was made. The endpoint was
secondary surgical intervention of the lumbar spine. Sta-
tistical analysis, comparing the pre- en post-operative MRI
dimensions, was performed using Students’ t-test.
Results
The pre-operative percentage of degenerative spondylolis-
thesis was less than 30% in all patients, with an average
slip of 19.6% ± 6.20 (9.6–29.7). In 9 out of the 12 patients
there was a slip of less than 25% (grade 1) degenerative
spondylolisthesis. Bending radiographs revealed mobility
at the level of the spondylolisthesis in all patients. MRI
showed nerve root compression and impingement of the
thecal sac. The mean anteroposterior axial cross-sectional
diameter was 7.33 mm (5.71–11.19) and the mean ante-
roposterior sagittal cross-sectional diameter was 7.32 mm
(5.40–8.49).
The operations were performed at L4–5 in ten of the
patients and at both L3–4 and L4–5 in two patients. A 14-
mm diameter X-Stop was implanted in nine levels. In the
remaining levels, a 12-mm implant was used three times,
and 16 and 10-mm implants both once. No peri-operative
complications were observed. Post-operative plain radio-
graphs showed a correct position of the implants in all
patients. No fractures of the spinous processes were
observed. The post-operative percentage of spondylolis-
thesis, measured on plain radiographs post-operatively and
at ﬁnal follow-up, remained unchanged in all patients.
Direct post-operatively, 8 out of 12 patient reported a
signiﬁcant improvement of pain, neurogenic claudication,
and radiculopathy. However, four patients did not experi-
ence any relief of symptoms following surgery and no
improvement at follow-up. At 12 weeks follow up, two
patients, that initially had experienced a relief of symptoms
suffered from a recurrence of pain, neurogenic claudication,
and radiculopathy. In addition, a third patient experienced a
recurrence of symptoms at 24 months follow-up.
All patients with persistent or recurrent symptoms had a
post-operative MRI. No statistically signiﬁcant (P[0.05)
difference of spinal stenosis was seen at the effected levels
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operative anteroposterior axial cross sectional diameter
was 6.80 mm (5.24–7.65) and the mean sagittal cross
sectional diameter was 6.91 mm (5.12–7.70) (Fig. 1, 2, 3).
The pre-operative axial and sagittal cross sectional diam-
eter in these seven patients (7 levels) was not signiﬁcantly
different (P[0.05) from that of the ﬁve patients (7 levels)
without persistent or recurrent symptoms. Finally, the
seven patients with persistent or recurrent symptoms
underwent surgical re-intervention. The mean degenerative
spondylolisthesis of these seven patients was 17.8% ± 6.9.
Six of these patients had a pre-operative degenerative
spondylolisthesis of less than 25%. One patient had a
27.6% degenerative spondylolisthesis. The X-Stop was
removed and a decompression and posterolateral fusion
with instrumentation was performed.
Discussion
The X-Stop interspinous distraction device has shown to be
an attractive alternative to conventional surgical proce-
dures in the treatment of symptomatic degenerative lumbar
spinal stenosis [4, 9]. It may be questioned, however, if the
X-stop will be effective in patients with lumbar spinal
stenosis caused by degenerative spondylolisthesis also. To
our best knowledge, there is only one study that investi-
gated the clinical effects of the X-Stop in patients with
lumbar spinal stenosis caused by degenerative spondylo-
listhesis [1]. In this study, 42 patients were treated with the
X-Stop and compared to 33 patients with non-operative
treatment. The indication for treatment was a percentage of
slip of less than 25%. An overall clinical success rate of
63.4% was reported in the X-Stop treated patients com-
pared to 12.9% in the non-operative treated patients after
2 year follow-up. Secondary surgery was required in 5
(11.9%) of the patients in the X-Stop group compared to 4
(12.1%) in the control group.
Unfortunately, we experienced an extremely high failure
rate, deﬁned as surgical re-intervention, in a cohort of
patients with lumbar spinal stenosis caused by degenerative
spondylolisthesis treated with the X-Stop interspinous
distraction device. In our cohort, the average percentage of
slip was less than 25%, though in 3 patients the percentage
of slip was between 25 and 30%. Surgical re-intervention
was required in 7 (58%) patients within 24 months. Of
Fig. 1 a Pre-operative lateral
plain radiograph. b Post-
operative lateral plain
radiograph. X-Stop positioned
at the level L4–5
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There was no relation between the severity of the slip and
the failures in our cohort. Our indication for re-intervention
included recurrence or persistent and unremitting low back
pain and persistent or progressive neurogenic claudication
with radiculopathy. Both clinical and radiological ﬁndings
were considered together for diagnosing failure of treat-
ment. Unfortunately, we did not enclose pre- and post-
operative outcome measurements. However, since the
surgical goal of the X-Stop include pain reduction,
improvement of neurological symptoms, and improvement
of quality of live, re-intervention was considered as the
endpoint for failure.
In diagnosing spinal stenosis, thecal sac impingement
and nerve root compression are seen on MRI. We observed
no improvement of the axial and sagittal diameter of the
central canal on the MRI after insertion of the X-Stop. In
addition, no relation was found between the severity of the
pre-operative spinal stenosis measured on MRI and an
eventual secondary surgical intervention. Recently, in a
study using positional MRI pre- and post-operatively fol-
lowing insertion of the X-Stop, improvement of the cross
sectional area of the dural sack has been observed in 12
patients with symptomatic spinal stenosis [11]. This study,
however, did not include patients with spinal stenosis
caused by degenerative spondylolisthesis. Unfortunately,
we do not have the opportunity to use the positional MRI.
It may be hypothesized that the spinal stenosis will be more
severe in a standing positional MRI, as a result of the
instability in degenerative spondylolisthesis. A limitation
of the present study is the lack of objective standards of
measurement spinal stenosis on MRI. Nevertheless, all
patients in our study showed pre-operative a severe thecal
sack impingement at the level of degenerative spondylo-
listhesis. In addition, the spondylolisthesis, as measured on
Fig. 2 Pre-operative T2-weighted a transversal and b sagittal MR
Image showing lumbar spinal stenosis due to discopathy, facet
arthritis, ligamentum ﬂavum hypertrophy and anterolisthesis
Fig. 3 Post-operative T2-weighted a transversal and b sagittal MR
Image. No change in canal cross-sectional area and mid-sagittal
diameter visible after insertion of the X-Stop at level L4–5
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or improvement after surgery.
From a biomechanical point of view, it may be ques-
tioned if the X-Stop interspinous distraction device
provides any stabilizing effect on the affected motion
segment and will increase the spinal canal in degenerative
spondylolisthesis. It has been shown that the facet joints in
patients with degenerative spondylolisthesis demonstrate
an increased sagittal orientation [5, 7]. When the facet
joints are orientated in a more sagittal plain, the resistance
to shear forces is decreased. Obviously, the more sagittal
orientation of the L4–L5 segment combined with an in-
terspinous distraction device may result in a progressive
forward slip of the superior vertebra, and a progressive
narrowing of the spinal canal and lateral recesses. Thus, the
presence of a degenerative spondylolisthesis in patients
with lumbar spinal stenosis may be considered as a contra
indication for the X-Stop.
In conclusion, the X-Stop interspinous distraction device
showed an extremely high failure rate, deﬁned as surgical
re-intervention, after short term follow-up in patients with
spinal stenosis caused by degenerative spondylolisthesis.
We do not recommend the X-Stop for the treatment of
lumbar spinal stenosis with degenerative spondylolisthesis,
and we consider a degenerative spondylolisthesis a contra-
indication for the X-Stop interspinous distraction device.
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